NUS, Agilent, and NUH launch new translational R&D hub to boost clinical diagnostics S$38 million research facility aims to be a premier, global, one-stop hub for research and translation to clinical testing through biochemical innovation and techniques Singapore, 19 August 2019 The National University of Singapore (NUS), Agilent Technologies, a global leader in life sciences,... Read more
Hilden, Germany, and Germantown, Maryland, August 14, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the publication of a multicenter clinical study demonstrating the accuracy of its QIAstat-Dx syndromic testing solution for diagnosing the causes of acute gastroenteritis. The QIAstat-Dx Gastrointestinal Panel delivered high performance compared to other, existing multiplex tests in this... Read more
AUGUST 09, 2019 BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the pricing of its previously announced underwritten public offering of 2,376,238 shares of its common stock at a public offering price of $25.25 per share. All of the shares... Read more
AUGUST 08, 2019 August 07, 2019 04:23 PM Eastern Daylight Time BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock. In connection with the... Read more
nSMOL™ Antibody BA Pretreatment Kit Shimadzu Corporation and Kyoto University developed the novel assay method of multiplexed analysis of therapeutic antibodies for the treatment of inflammatory immune diseases.1) The antibodies were measured using an LCMS-8050/8060 high-performance liquid chromatograph triple quadrupole mass spectrometer and nSMOLTM Antibody BA Kit2). The results of the joint research were published on... Read more
New Instrument for Automated Antimicrobial Susceptibility Testing Provides Gold Standard-Level Minimum Inhibitory Concentration (MIC) Accuracy[1] Instrument utilizes gold standard broth microdilution method to guide more targeted patient therapy and optimize patient outcomes ANAHEIM, Calif., Aug. 6, 2019 /PRNewswire/ — AACC 2019 – A new benchtop automated reading and incubation system for antimicrobial susceptibility testing (AST) provides microbiology... Read more
New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for performing laboratory developed tests ANAHEIM, Calif. – AACC 2019 – (August 6, 2019) – Thermo Fisher Scientific has expanded its portfolio of analytical... Read more
ImmunoCAP Allergen Components test for specific proteins that cause allergic sensitization to dogs, cats and horses ANAHEIM, Calif. – AACC 2019 – (August 6, 2019)—New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity... Read more
Thermo Fisher Scientific Showcases New Innovations for the Clinic During AACC 2019 ANAHEIM, Calif. – AACC 2019 – (August 6, 2019) – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest instruments, assays and software for improving speed, accuracy and usability across clinical and research labs during the... Read more
Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY, August 5, 2019 — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and... Read more